Adenosine is an intravenously administered medication with a duration of action lasting only a few seconds. In the field of cardiac arrhythmias, it constitutes the treatment of choice for the immediate termination (cardioversion) of atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) involving an accessory pathway.
Adverse Effects
Due to the ultra-short duration of action of the drug (lasting only seconds), adverse effects are typically completely transient. They may include:
Discomfort, chest pain, transient dyspnea, dizziness, and syncope resulting from atrioventricular (AV) block.
An electrocardiogram (ECG) demonstrating the termination of supraventricular tachycardia (SVT) at a rate of 200 beats per minute (bpm) following the intravenous administration of adenosine.